Drug Safety
Hesitancy around Steroids and Vaccines: Dr. Kevin Winthrop
OHSU's Dr. Kevin Winthrop discusses two issues -- steroids and vaccines -- by looking at abstracts #1014, #0632, #0634 and #1135 at ACR 2020.
A New Pathway in Psoriatic Arthritis: Dr. Eric Ruderman
Dr. Ruderman discusses a new pathway - the use of deucravacitinib - for the treatment of psoriatic arthritis (abstracts L03) at the ACR 2020 annual meeting.
Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway
Dr. Conway discusses ACR abstract #1445 presented Sunday at the ACR annual meeting.
Check on Pneumococcal Vaccination: Dr. Janet Pope
Dr. Janet Pope reviews abstracts #0456 and #0457 presented at the 2020 ACR annual meeting.
Improving Response to Pegloticase: Dr. Nicola Dalbeth
Auckland-based rheumatologist Dr. Nicola Dalbeth discusses improving responses to the use of Pegloticase, including abstracts #0677 and #0952.
Warfarin and Risk of Hip and Knee Replacements: Dr. Mrinalini Dey
Dr. Mrinalini Dey reviews abstract #0934 presented Saturday at the 2020 ACR annual meeting.
Warfarin and End-Stage Osteoarthritis: Dr. David Liew
Dr. David Liew discusses abstract #0934 presented at the 2020 ACR annual meeting.
SEAM-RA Trial: Dr. Jeff Curtis
Dr. Jeff Curtis discusses abstract #0939, which looked at whether RA patients at or close to remission should continue taking their combination therapy, as presented at ACR 2020.
HCQ and QTc Prolongation: Dr David Liew
Dr. David Liew reviews abstracts #0431 presented at the ACR 2020 annual meeting - and shares the results of the Twitter poll he conducted asking when prescribing HCQ, is an EKG routinely ordered either before or doing.
Safety of JAKs: Venous Thromboembolic Risk: Dr. Kevin Winthrop
OHSU rheumatologist Dr. Kevin Winthrop in Portland looks at two posters -- abstracts #0215 and #0229 presented Friday at ACR 2020.
Poster Hall